Tailored nutrition after pancreatic surgery could speed recovery
NCT ID NCT07703813
First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time
Summary
This study looks at the energy needs of people who have surgery to remove part or all of the pancreas for a tumor. After such surgery, patients often have trouble eating enough and may need special nutrition. The study measures how many calories patients actually burn and compares that to standard formulas, to see if better nutrition plans can improve recovery and reduce complications.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could lead to better, individualized nutrition plans for patients recovering from pancreatic surgery, potentially reducing complications and improving recovery.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results may not apply to all patients or hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 150 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2017
- Expected to finish
-
Nov 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Consecutive adult patients admitted for total or partial pancreatectomy - including pancreaticoduodenectomy (Whipple procedure) and distal pancreatectomy - for a pancreatic tumor at the participating surgical center. The cohort reflects the real-world case mix referred for pancreatic resection and therefore includes both malignant tumors and premalignant or benign lesions (such as intraductal papillary mucinous neoplasm and ampullary tumors), spanning the head, body, and tail of the pancreas. Participants are enrolled preoperatively and followed through the early postoperative period and to 3-6 months after discharge. Within this single cohort, the postoperative feeding route (enteral with oral intake, parenteral, or combined) is observed rather than assigned and is analyzed as an exposure of interest.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18 years or older * Scheduled to undergo total or partial pancreatectomy (including pancreaticoduodenectomy/Whipple procedure or distal pancreatectomy) for a pancreatic tumor * Able to complete indirect calorimetry measurement by canopy or face mask for the required duration * Able to provide written informed consent Exclusion Criteria: * Age under 18 years, greater than 75 years * Pregnancy * Inability to tolerate the calorimetry canopy or mask for the duration required for a valid measurement * Unable or unwilling to provide informed consent * patients already on preoperative enteral nutrition or unable to feed orally preoperatively
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pancreatic cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Evaggelismos General Hospital
RECRUITINGAthens, Attica, 10676, Greece
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Real-Time application of a validated artificial intelligence model during digital Per-Oral pancreatoscopy for identification of pancreatic neoplastic lesions and IPMN: a prospective pilot diagnostic accuracy study
- Can a pill duo outsmart a Hard-to-Treat pancreatic cancer mutation?
- Can a new drug combo outsmart RAS-Mutated pancreatic cancer?
- Can protein patterns in stored tumors point to new treatment targets?
- AI takes aim at pancreatic cancer: can it forecast chemotherapy outcomes?
- Can a triple therapy shrink pancreatic tumors enough for complete surgery?